434
Views
5
CrossRef citations to date
0
Altmetric
Perspective

An evidence-based multidisciplinary approach focused at creating algorithms for targeted therapy of infection-related ventilator associated complications (IVACs) caused by Enterobacterales in critically ill adult patients

, , , ORCID Icon &
Pages 331-352 | Received 04 Jun 2021, Accepted 13 Aug 2021, Published online: 24 Sep 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (4)

Keith S. Kaye, Thierry Naas, Jason M. Pogue & Gian Maria Rossolini. (2023) Cefiderocol, a Siderophore Cephalosporin, as a Treatment Option for Infections Caused by Carbapenem-Resistant Enterobacterales. Infectious Diseases and Therapy 12:3, pages 777-806.
Crossref
Milo Gatti, Pier Giorgio Cojutti, Michele Bartoletti, Tommaso Tonetti, Amedeo Bianchini, Stefania Ramirez, Giacinto Pizzilli, Simone Ambretti, Maddalena Giannella, Rita Mancini, Antonio Siniscalchi, Pierluigi Viale & Federico Pea. (2022) Expert clinical pharmacological advice may make an antimicrobial TDM program for emerging candidates more clinically useful in tailoring therapy of critically ill patients. Critical Care 26:1.
Crossref
Maria Sanz Codina, Milo Gatti, Carla Troisi, Giacomo Fornaro, Zeno Pasquini, Filippo Trapani, Andrea Zanoni, Fabio Caramelli, Pierluigi Viale & Federico Pea. (2022) Relationship between Pharmacokinetic/Pharmacodynamic Target Attainment and Microbiological Outcome in Critically Ill COVID-19 Patients with Documented Gram-Negative Superinfections Treated with TDM-Guided Continuous-Infusion Meropenem. Pharmaceutics 14:8, pages 1585.
Crossref
Pier Giorgio Cojutti, Giacomo Fornaro, Milo Gatti, Matteo Rinaldi, Paolo Gaibani, Maddalena Giannella, Federico Pea & Pierluigi Viale. (2022) Successful Treatment of Bacteremia and Ventilator-Associated Pneumonia Caused by KPC/OXA-48-like Klebsiella pneumoniae Co-Producer with a Continuous Infusion of High-Dose Meropenem Plus Fosfomycin Guided by Real-Time Therapeutic Drug Monitoring. Infectious Disease Reports 14:1, pages 88-92.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.